Oruka Therapeutics (ORKA) EBT Growth (1y) (2011 - 2024)
Powered by 
Analysis
Oruka Therapeutics (ORKA) EBT Growth (1y) (2011 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | 8.48% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 0.60% |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | 88.92% |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | 6.23% |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 213.87% |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 530.43% |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | -12.04% |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 96.45% |
| 10 | Oruka Therapeutics | 5.89 Bn | 4.16 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | -80.95% |
| Mar 31, 2024 | -49.26% |
| Dec 31, 2023 | 7.24% |
| Sep 30, 2023 | 38.96% |
| Jun 30, 2023 | 52.97% |
| Mar 31, 2023 | 58.86% |
| Dec 31, 2022 | 79.32% |
| Sep 30, 2022 | 50.49% |
| Jun 30, 2022 | 34.90% |
| Mar 31, 2022 | 20.20% |
| Dec 31, 2021 | -10.75% |
| Sep 30, 2021 | -136.66% |
| Jun 30, 2021 | -268.73% |
| Mar 31, 2021 | -210.61% |
| Dec 31, 2020 | -312.64% |
| Sep 30, 2020 | -66.19% |
| Jun 30, 2020 | 10.39% |
| Mar 31, 2020 | 24.40% |
| Dec 31, 2019 | 16.59% |
| Sep 30, 2019 | 26.23% |